This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Top Executive Joins Caliber Imaging & Diagnostics, Inc.

ROCHESTER, N.Y., Jan. 7, 2013 /PRNewswire/ -- Caliber Imaging & Diagnostics, Inc., (Caliber I.D.) formerly Lucid, Inc. (OTBB: LCDX) announced today that Utica, NY native, Rick Stathes, has joined Caliber Imaging & Diagnostics, Inc. as Vice President of Sales and Marketing.

"I'm excited for the opportunity to be part of this innovative team," said Mr. Stathes.  "I have no doubt that our products will have a huge impact on improving the standards of care in many areas of medical diagnosis and treatment.  Our products give clinicians and researchers a non-invasive window into the skin."

Mr. Stathes has over 25 years of executive experience with technology driven companies, including American Aerogel Corporation, Conseco Insurance, Centennial Technologies, PSC Inc. and Hewlett Packard Company, is a Veteran of the United States Air Force and has his BS degree in Business from Utica College of Syracuse University.

As Vice President of Sales and Marketing, Mr. Stathes will focus on opening new channels of distribution, building customer support infrastructure, expanding the sales force, targeting new applications for the technology, and creating more awareness of the technology in domestic and international markets. Additionally, he is looking forward to developing relationships with academic centers to increase adoption of the technology in research and clinical applications through accredited training programs.

"Caliber I.D. is poised for high growth with the introduction of its new hand-held portable medical imaging devices, and Rick with his extensive experience in sales and marketing, is a perfect fit for our company at this time," said L. Michael Hone, President and CEO at Caliber I.D.

Mr. Hone went on to say that, "We believe that Caliber I.D. has raised the bar in non-invasive, cellular imaging with an FDA-cleared imaging technology platform-the VivaScope®- that introduces clinicians and researchers to a powerful new world in which living cells and cellular processes can be viewed in real-time without a biopsy."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs